Equities

Adapthealth Corp

AHCO:NAQ

Adapthealth Corp

Actions
  • Price (USD)17.87
  • Today's Change0.01 / 0.06%
  • Shares traded984.26k
  • 1 Year change-51.77%
  • Beta0.3610
Data delayed at least 15 minutes, as of Jan 27 2022 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

AdaptHealth Corp. is a provider of patient-centric and technology-enabled chronic disease management solutions. The Company provides home healthcare equipment, medical supplies to the home and related services in the United States. It is focused primarily on providing sleep therapy equipment, supplies and related services to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes, home medical equipment (HME) to patients discharged from acute care and other facilities. The Company also offers oxygen and related chronic therapy services in the home, and other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial payors.

  • Revenue in USD (TTM)2.12bn
  • Net income in USD-42.36m
  • Incorporated2017
  • Employees8.70k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AHCO:NAQ since
announced
Transaction
value
Home Medical Products & Services IncDeal completed30 Nov 202130 Nov 2021Deal completed-11.27%--
Upstate HomeCareDeal completed01 Jul 202101 Jul 2021Deal completed-34.80%--
Healthy Living Medical Supply LLCDeal completed01 Jun 202101 Jun 2021Deal completed-31.77%--
Data delayed at least 15 minutes, as of Jan 27 2022 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Outset Medical Inc91.70m-122.75m1.64bn313.00--3.99--17.86-2.77-2.772.068.710.20053.776.95292,961.70-26.83---29.21--5.13---133.86--9.64-90.750.0677--231.18--7.18------
Lantheus Holdings Inc389.80m-34.48m1.64bn595.00--3.29410.274.22-0.5112-0.51125.787.380.45136.126.88655,122.70-3.996.05-4.406.9643.8047.97-8.847.432.18-4.080.26180.00-2.282.95-142.55---1.05--
Cytek Biosciences Inc-100.00bn-100.00bn1.80bn462.00--4.47----------3.01------------------------13.74--0.00--60.39--119.11------
Fulgent Genetics Inc1.04bn569.33m1.80bn429.003.141.743.151.7419.2419.2434.6534.761.43--9.722,414,664.0077.8233.2591.1738.1280.1974.6654.5439.63----0.01980.001,196.46113.1952,243.55--75.67--
Axonics Inc161.94m-76.25m2.03bn416.00--4.13--12.51-1.83-1.833.9010.590.35631.047.31389,274.00-16.78---18.10--63.27---47.09--9.36-8.100.0002--707.06--31.30------
Pacific Biosciences of California Inc121.63m-36.96m2.08bn412.00--2.47--17.08-0.2459-0.24590.58353.810.10423.986.80295,218.40-3.17-37.11-3.44-46.5343.9839.54-30.39-74.8619.99-15.360.5159---13.20-3.19134.95---19.16--
Nevro Corp393.88m-108.36m2.19bn843.00--6.86--5.56-3.12-3.1211.359.150.57891.355.54467,231.30-15.92-12.91-20.71-15.3269.8069.17-27.51-17.965.97-2.920.318---7.2339.0719.89--3.77--
Haemonetics Corporation933.83m31.24m2.24bn2.71k72.373.2018.262.400.60490.604918.2613.680.58011.596.60344,839.401.943.922.414.9146.6146.023.355.591.315.840.52780.00-11.94-0.8593.85---18.40--
Glaukos Corp294.01m-38.37m2.28bn653.00--3.79--7.74-0.8477-0.84776.3112.830.28563.508.63450,237.40-3.73-6.01-3.94-6.6076.4178.99-13.05-12.377.60-3.740.3697---5.0725.69-880.26---15.27--
Adapthealth Corp2.12bn-42.36m2.36bn8.70k--1.1916.581.12-1.60-1.6018.0715.060.627622.838.55243,119.00-1.87---2.13--21.01---2.98--1.441.580.5278--102.15---657.38------
Integer Holdings Corp1.18bn88.45m2.53bn7.50k28.811.9014.962.152.662.6635.4340.350.49075.555.50156,936.403.692.293.942.4727.8929.447.515.191.884.540.32130.00-14.686.05-15.30--2.89--
NuVasive, Inc.1.13bn-25.66m2.59bn2.70k--3.1421.402.29-0.4976-0.497621.8515.950.47121.055.58418,044.40-1.071.55-1.361.8171.3572.62-2.272.572.351.770.51760.00-10.065.31-156.95--0.3312--
Patterson Companies, Inc.6.38bn159.84m2.71bn7.80k17.012.6811.310.42531.641.6465.2210.372.246.4013.10817,576.705.58-0.34759.28-0.49220.1121.732.49-0.19960.8125--0.3844--7.691.88126.51-3.43-20.132.93
AtriCure Inc.258.84m45.38m2.73bn750.0064.145.5849.4610.540.92590.92595.8210.630.3921.808.78345,114.706.87-8.447.43-9.3574.6772.6717.53-17.002.9130.380.1215---10.529.74-36.83---17.12--
Merit Medical Systems, Inc.1.05bn43.22m2.97bn5.99k69.022.9322.862.820.76280.762818.5517.950.63632.817.20176,033.202.611.362.971.5244.3643.604.102.171.2013.450.21570.00-3.1112.20-280.57---1.41--
Agape ATP Corp1.32m-1.46m3.01bn35.00--703.15--2,277.13-0.0039-0.00390.00350.01140.21530.54099.5637,787.14-23.82---28.05--79.79---110.61--4.27-49.540.00--------------
Data as of Jan 27 2022. Currency figures normalised to Adapthealth Corp's reporting currency: US Dollar USD

Institutional shareholders

27.47%Per cent of shares held by top holders
HolderShares% Held
Deerfield Management Company LPas of 30 Sep 20218.10m6.13%
The Vanguard Group, Inc.as of 30 Sep 20216.86m5.19%
BlackRock Fund Advisorsas of 30 Sep 20214.66m3.53%
Viking Global Investors LPas of 30 Sep 20214.07m3.08%
Wellington Management Co. LLPas of 30 Sep 20212.94m2.22%
Silvercrest Asset Management Group LLCas of 30 Sep 20212.52m1.90%
Rubric Capital Management LPas of 30 Sep 20212.30m1.74%
Swedbank Robur Fonder ABas of 30 Nov 20211.72m1.30%
Maverick Capital Ltd.as of 30 Sep 20211.60m1.21%
SSgA Funds Management, Inc.as of 30 Sep 20211.56m1.18%
More ▼
Data from 30 Sep 2021 - 30 Nov 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.